pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

1,126 catalysts · 18,987 approval · 5,000 device 510k · 4,779 phase readout · 4,728 grant · 2,387 8k filing · 2,000 device pma

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 0 catalysts2026-07-23: 0 catalysts2026-07-24: 1 catalyst2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
hide past →
sort
soonestlatesttypesponsoralpha
type: recall×clear all
type
  • approval18,987
  • device 510k5,000
  • phase readout4,779
  • grant4,728
  • 8k filing2,387
  • device pma2,000
  • device recall2,000
  • recall1,126
  • device adverse event1,000
  • earnings295
  • therapy area

    no tagged catalysts yet

    Week of Mar 17, 2025

    13
    ›Mar 19, 2025recall492d agoBreckenridge Pharmaceutical, Inc. recall (Cls II)Breckenridge Pharmaceutical Inc

    Duloxetine Delayed-Release Capsules, USP, 20mg, Rx Only, 500-count bottles, Mfr. by: Towa Pharmaceutical Europe, S.L. Martorelles, (Barcelona), Spain, Dist. by: Breckenridge Pharmaceuticals, Inc., Berkeley Heights, NJ 07922. NDC 51991-746-05 — Reason: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit. — Status: Ongoing

    full page →fda recalls ↗
    ›Mar 19, 2025recall492d agoAspen Biopharma Labs Pvt., Ltd. recall (Cls II)PFIZER INC

    Alprostadil Container Description: Amber color bottle — Reason: CGMP Deviations — Status: Ongoing

    full page →fda recalls ↗
    ›Mar 19, 2025recall492d agoBreckenridge Pharmaceutical, Inc. recall (Cls II)Breckenridge Pharmaceutical Inc

    Duloxetine Delayed-Release Capsules, USP, 30mg, Rx Only, 1000-count bottles, Mfr. by: Towa Pharmaceutical Europe, S.L. Martorelles, (Barcelona), Spain, Dist. by: Breckenridge Pharmaceuticals, Inc., Berkeley Heights, NJ 07922. NDC 51991-747-10 — Reason: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit. — Status: Ongoing

    full page →fda recalls ↗
    ›Mar 19, 2025recall492d agoNephron Sterile Compounding Center LLC recall (Cls II)Revalesio Corp

    Sodium Chloride Injection 9%, USP, 500 mL, Single-Dose IV Bottle, Rx Only, nephron, 503B outsourcing facility, West Columbia, SC 29172, NDC: 69374-334-50 — Reason: Lack of Assurance of Sterility: There is a potential for leakage at the IV bottle port. — Status: Terminated

    full page →fda recalls ↗
    ›Mar 19, 2025recall492d agoAspen Biopharma Labs Pvt., Ltd. recall (Cls II)SpyGlass Pharma, Inc.

    Bimatoprost NDC# 82187-1001-1 Container description: The product packed in double self-seal cover and finally packed in Aluminum cover for shipping. — Reason: CGMP Deviations — Status: Ongoing

    full page →fda recalls ↗
    ›Mar 19, 2025recall492d agoCentral Admixture Pharmacy Services, Inc. recall (Cls I)Revalesio Corp

    PHENYLephrine added to 0.9% sodium chloride, 40 mg/250 mL* (160 mcg/mL), Rx Only, CAPS, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, 855-275-2270, NDC 71285-6092-1. — Reason: Presence of Particulate Matter — Status: Ongoing

    full page →fda recalls ↗
    ›Mar 19, 2025recall492d agoBreckenridge Pharmaceutical, Inc. recall (Cls II)Breckenridge Pharmaceutical Inc

    Duloxetine Delayed-Release Capsules, USP, 60mg, Rx Only, 1000-count bottles, Mfr. by: Towa Pharmaceutical Europe, S.L. Martorelles, (Barcelona), Spain, Dist. by: Breckenridge Pharmaceuticals, Inc., Berkeley Heights, NJ 07922. NDC 51991-748-10 — Reason: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit. — Status: Ongoing

    full page →fda recalls ↗
    ›Mar 19, 2025recall492d agoSigan Industries Group Inc. recall (Cls II)AIR INDUSTRIES GROUP

    Walgreens, Acne Control Cleanser, 10% Benzoyl Peroxide/Acne Treatment, NET WT 5 OZ (142g) Distributed by: Walgreen CO, 200 Wilmont RD, Deerfield, IL, Made in Canada. UPC#: 1 9560203602 8 — Reason: Chemical Contamination: Presence of benzene — Status: Ongoing

    full page →fda recalls ↗
    ›Mar 19, 2025recall492d agoAspen Biopharma Labs Pvt., Ltd. recall (Cls II)BioLight Israeli Life Sciences Ltd

    Latanoprost NDC# 82187-1002-1 Container Description: Amber colour bottle — Reason: CGMP Deviations — Status: Ongoing

    full page →fda recalls ↗
    ›Mar 19, 2025recall492d agoICU Medical, Inc. recall (Cls I)ICU MEDICAL INC/DE

    POTASSIUM CHLORIDE Inj., 20 mEq total in 100 mL flexible container 24 x case, 200 mEq/L, Rx Only, ICU Medical, Inc., Lake Forest, Illinois, 60045, USA, NDC# 0990-7075-26; Bar Code Flexible container (01) 00309907075266; Case (01)30309907075267 — Reason: Labeling: Label Error on Declared Strength. Cases labeled POTASSIUM CHLORIDE 20 mEq, may contain flexible containers with overwrap mislabeled as 10 mEq. The correct dosage strength of 20 mEq is printed on the labeling affixed to the product flexible container. — Status: Ongoing

    full page →fda recalls ↗
    ›Mar 19, 2025recall492d agoJohnson, S C and Son, Inc recall (Cls II)

    Kids by babyganics SPF 50 totally tropical (titanium dioxide 3/5%, zinc oxide 7.25%) packaged in a) 6 OZ (170 g) spray bottles UPC 813277019954 and UPC 813277019800; and b) Twinpack UPC 813277019930; Dist. by KAS Direct LLC, 1525 Howe St. Racine, WI 53403. — Reason: Chemical Contamination — Status: Ongoing

    full page →fda recalls ↗
    ›Mar 19, 2025recall492d agoCareFusion 213, LLC recall (Cls I)Coorg Instituite of Dental Sciences

    BD ChloraPrep Clear 1mL Applicators, 2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA), Patient Preoperative Skin Preparation, Sterile Solution, 0.03 fl. oz (1 mL) each, 60 Applicators per Carton, CareFusion 213, LLC, El Paso, TX 79912, Subsidiary of Becton, Dickinson and Co., REF 930480, NDC 54365-400-31. — Reason: Non-Sterility: contamination of Aspergillus penicillioides, due to breach in package lidding. — Status: Ongoing

    full page →fda recalls ↗
    ›Mar 19, 2025recall492d agoAspen Biopharma Labs Pvt., Ltd. recall (Cls II)Greenstone LLC

    Voriconazole Container Description: voriconazole The product packed in white poly bag containing black poly bag and tied each individual finally packed in HDPE container for shipping. — Reason: CGMP Deviations — Status: Ongoing

    full page →fda recalls ↗

    Week of Mar 24, 2025

    15
    ›Mar 26, 2025recall485d agoFruit Of The Earth, Inc. recall (Cls II)CVS HEALTH Corp

    CVS Health Concealing Acne Treatment Cream, CVS, 10% benzoyl peroxide, 1 oz (28 g), Distributed by: CVS Pharmacy, Inc — Reason: Chemical contamination: presence of benzene — Status: Ongoing

    full page →fda recalls ↗
    ›Mar 26, 2025recall

    Week of Mar 31, 2025

    12
    ›Apr 2, 2025recall478d agoA-S Medication Solutions LLC recall (Cls II)A-S Medication Solutions LLC

    METFORMIN HYDROCHLORIDE EXTENDED- RELEASE 500MG, 180 TABLETS, Packaged BY: A-S Medication Solutions, Libertyville, IL 60048 NDC 50090-1494-3. — Reason: Presence of Foreign Tablets/Capsules. — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 2, 2025recall

    Week of Apr 7, 2025

    6
    ›Apr 9, 2025recall471d agoBIOCON PHARMA INC recall (Cls II)Pharma-Bio Serv, Inc.

    Atorvastatin Calcium Tablets USP 40 mg, 1000-count bottle, Rx Only, Manufactured for: Biocon Pharma Inc., Iselin, NJ 08830-3009 USA, Manufactured by: Recipharm Pharmaservices PVT, Ltd Bengaluru, INDIA -562-123, NDC 70377-079-13 — Reason: Failed dissolution specifications: lower than specifications — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 9, 2025

    Week of Apr 14, 2025

    4
    ›Apr 16, 2025recall464d agoSomerset Therapeutics Private Limited recall (Cls II)Somerset Therapeutics LLC

    Haloperidol Decanoate Injection 50mg/mL, 1mL Single-Dose Vial, Rx Only, Manufactured by: Somerset Therapeutics Limited, Kamataka India, Manufactured for: BluePoint Laboratories NDC 68001-580-41 — Reason: Lack of Assurance of Sterility: Media fill with bacterial contamination — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 16, 2025
    ← prev
    page 6 of 23
    next →
    485d ago
    Amgen, Inc. recall (Cls II)AMGEN INC

    Neupogen (filgrastim) For Injection, 300mcg/1 mL, 1 mL Single Dose Vials, Rx Only, For Subcutaneous or Intravenous Use Only, Sterile Solution - No Preservative, Amgen Inc., Thousand Oaks, CA 91320, NDC 55513-530-01 (vial), NDC 55513-530-10 (box). — Reason: Stability data does not support expiry: the products have the potential to be out of specification at the time of expiry of 36-months. — Status: Ongoing

    full page →fda recalls ↗
    ›Mar 26, 2025recall485d agoMYLAN PHARMACEUTICALS INC recall (Cls II)MIRA PHARMACEUTICALS, INC.

    Prasugrel Tablets, USP, 5 mg, 30-count bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A., NDC 0378-5185-93 — Reason: Failed Dissolution Specifications - low dissolution results — Status: Ongoing

    full page →fda recalls ↗
    ›Mar 26, 2025recall485d agoFDC Limited recall (Cls II)FDC Ltd

    Ciprofloxacin Ophthalmic Solution USP, 0.3% as base, package in 5 mL bottles, Rx Only, Distributed by: Leading Pharma LLC, Fairfield, NJ. Manufactured by: FDC Limited, Maharashtra, India, NDC 69315-308-05 — Reason: Defective container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle — Status: Ongoing

    full page →fda recalls ↗
    ›Mar 26, 2025recall485d agoMylan Institutional, Inc. recall (Cls II)Mylan Institutional Inc

    Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), Rx Only, 100 Unit Dose Blister Cards of 10 (10 cards of 10 tablets each) per carton, Mylan Pharmaceuticals Inc., Morgantown, WV 26505, Made in India, NDC 51079-443-20. — Reason: Super-Potent Drug: Out of specification potency results were obtained. — Status: Ongoing

    full page →fda recalls ↗
    ›Mar 26, 2025recall485d agoSlate Run Pharmaceuticals recall (Cls II)Slate Run Pharmaceuticals LLC

    Cinacalcet Hydrochloride Tablets 60 mg, 30-count bottle, Rx only, Distr. by: Slate Run Pharma., LLC, Columbus, Ohio 43215, Mfg. by: Piramal Pharma Limited, Madhya Pradesh, India, NDC 70436-008-04 — Reason: CGMP deviations: The presence of nitrosamine impurity above the acceptable daily intake limits. — Status: Ongoing

    full page →fda recalls ↗
    ›Mar 26, 2025recall485d agoMEDLINE INDUSTRIES, LP - Northfield recall (Cls II)

    CURAD Alcohol Prep Pads, Sterile, Medium, 2-Ply, Contents: 5 boxes per Carton, 30 Boxes per Case, Single Use Only, Manufactured for Medline Industries, LP, Three Lakes Drive, Northfield, IL 60093, USA, Made in India, www.curad.com, 1-800-633-5463, NDC 53329-827-30. — Reason: Subpotent Drug — Status: Ongoing

    full page →fda recalls ↗
    ›Mar 26, 2025recall485d agoMEDLINE INDUSTRIES, LP - Northfield recall (Cls II)

    Medline Alcohol Prep Pads, 70% Isopropyl Alcohol, 100 Sterile 2-Ply Pads, Single Use Only, Large, www.medline.com, Manufactured for Medline Industries, LP, Three Lakes Drive, Northfield, IL 60093 USA, 1-800-MEDLINE, NDC 53329-811-30. — Reason: Subpotent Drug — Status: Ongoing

    full page →fda recalls ↗
    ›Mar 26, 2025recall485d agoFruit Of The Earth, Inc. recall (Cls II)Galderma Laboratories LP

    Walgreens Maximum Strength Tinted Acne Treatment Cream 10% Benzoyl Peroxide/Acne Medication, 0.65 oz (18.4g) tube in a carton; Distributed by: Walgreen CO., 200 Wilmot Rd., Deerfield, IL 60015 — Reason: Chemical contamination: presence of benzene — Status: Ongoing

    full page →fda recalls ↗
    ›Mar 26, 2025recall485d agoOne Source Nutrition, Inc, recall (Cls I)Shenzhen Hanhui Pharmaceutical Technology Co Ltd

    Vitality, Fast Acting Male Enhancement Product, Dietary Supplement, a) One Capsule per Packet, b) 6 capsules per bottle, Xtreme Potency. — Reason: Marketed without an approved NDA/ANDA: Product found to be tainted with undeclared sildenafil and tadalafil. — Status: Ongoing

    full page →fda recalls ↗
    ›Mar 26, 2025recall485d agoAmgen, Inc. recall (Cls II)AMGEN INC

    Neupogen (filgrastim) For Injection, 480 mcg/1.6 mL (300 mcg/1 mL), 1.6 mL single Dose Vial, Rx Only, For Subcutaneous or Intravenous Use Only, Sterile Solution - No Preservative, Amgen Inc. Thousand Oaks, CA 91320, NDC 55513-546-01 (vial), NDC 55513-546-10 (box). — Reason: Stability data does not support expiry: the products have the potential to be out of specification at the time of expiry of 36-months. — Status: Ongoing

    full page →fda recalls ↗
    ›Mar 26, 2025recall485d agoMylan Institutional, Inc. recall (Cls II)Mylan Institutional Inc

    Levothyroxine Sodium Tablets, USP, 150 mcg (0.15 mg), Rx Only, 100 Unit Dose Blister Cards of 10 (10 cards of 10 tablets each) per carton, Mylan Pharmaceuticals Inc., Morgantown, WV 26505, Made in India, NDC 51079-445-20. — Reason: Super-Potent Drug: Out of specification potency results were obtained. — Status: Ongoing

    full page →fda recalls ↗
    ›Mar 26, 2025recall485d agoSlate Run Pharmaceuticals recall (Cls II)Slate Run Pharmaceuticals LLC

    Cinacalcet Hydrochloride Tablets 30 mg, 30-count bottle, Rx only, Distr. by: Slate Run Pharma., LLC, Columbus, Ohio 43215, Mfg. by: Piramal Pharma Limited, Madhya Pradesh, India, NDC 70436-007-04 — Reason: CGMP deviations: The presence of nitrosamine impurity above the acceptable daily intake limits. — Status: Ongoing

    full page →fda recalls ↗
    ›Mar 26, 2025recall485d agoGolden State Medical Supply Inc. recall (Cls II)Apotex Corp

    PRASUGREL TABLETS, 5 mg, 30 tablet bottles, Rx only, packaged by GSMS, Incorporated, Camarillo, CA 93012 NDC 51407-444-30 — Reason: Failed Dissolution Specifications — Status: Ongoing

    full page →fda recalls ↗
    ›Mar 26, 2025recall485d agoRising Pharma Holding, Inc. recall (Cls II)CHINA PHARMA HOLDINGS, INC.

    Duloxetine Delayed-Release Capsules, USP, 30 mg, 1,000-count bottle, Rx only, Distributed by: Rising Health, LLC, Saddle Brook, NJ 07663, NDC 57237-018-99 — Reason: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit. — Status: Ongoing

    full page →fda recalls ↗
    478d ago
    QuVa Pharma, Inc. recall (Cls II)IGC Pharma, Inc.

    fentaNYL Citrate PF 200 mcg/100 mL (2 mcg/ml) /0.125% Bupivacaine HCl 125 mg/100 mL (1.25 mg/mL), 100 ml in NS Yellow CADD FSFF, Injection for Epidural Use (Not intended For IV Use), Compounded, For Institutional or Office Use Only, QuVa Pharma, 1075 West Park One Drive, Suite 100, Sugar Land, Tx 77478. NDC: 70092-1255-75 — Reason: Lack of Assurance of Sterility — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 2, 2025recall478d agoConsumer Product Partners, LLC recall (Cls II)Kortuc Japan LLC

    [CORRECT FRONT PANEL] Hydrogen Peroxide Topical Solution, USP, 32 FL OZ (1 QT) 946 mL per bottle, NDC 0869-0871-45; [INCORRECT BACK LABEL] Isopropyl alcohol 91%, Dist. by: Amazon.com Services, LLC, Seattle, WA 98109. — Reason: Labeling; Label Mixup; some bottles have an incorrect back label indicating 91% Isopropyl Alcohol — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 2, 2025recall478d agoExela Pharma Sciences LLC recall (Cls II)Exela Pharma Sciences LLC

    8.4% Sodium Bicarbonate Injection, USP, 50 mEq/50 mL (1 mEq/mL), 25 x 50 mL Single Dose Vials per carton, For Intravenous Use Only, Rx Only, Manufactured by: Exela Pharma Sciences, LLC, Lenoir, NC 28645. NDC Inner Vial: 51754-5001-1; NDC Carton: 51754-5001-4 — Reason: Lack of Assurance of Sterility — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 2, 2025recall478d agoAscent Consumer Products Inc. recall (Cls I)Reynolds Consumer Products Inc.

    SinuCleanse Soft Tip Squeeze Bottle Nasal Wash System (sodium bicarbonate USP 700 mg and sodium chloride USP 2300 mg), 30-count All Natural USP Grade Saline Packets and 1 Soft tip Squeeze Bottle, Net WT 0.1OZ (3g) each, Distributed by Ascent Consumer Products Inc., Melville, NY 11747, UPC 6 46011 00104 1 — Reason: Microbial Contamination of Non-Sterile Products: Bacterial contamination with Staphylococcus aureus — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 2, 2025recall478d agoAscent Consumer Products Inc. recall (Cls I)Reynolds Consumer Products Inc.

    SinuCleanse Soft Tip NETI POT Nasal Wash System (sodium bicarbonate USP 700 mg and sodium chloride USP 2300 mg), 30-count All Natural USP Grade Saline Packets and 1 kettle style Neti Pot, Net WT 0.1OZ (3g) each, Distributed by Ascent Consumer Products Inc., Melville, NY 11747, UPC 6 46011 00102 7 — Reason: Microbial Contamination of Non-Sterile Products: Bacterial contamination with Staphylococcus aureus — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 2, 2025recall478d agoQuVa Pharma, Inc. recall (Cls II)IGC Pharma, Inc.

    fentaNYL Citrate PF 200 mcg/100 mL (2 mcg/ml) /0.1% Bupivacaine HCl 100 mg/100 mL (1 mg/mL), 100 ml in NS Yellow CADD FSFF, Injection for Epidural Use (Not intended For IV Use), Compounded, For Institutional or Office Use Only, QuVa Pharma, 1075 West Park One Drive, Suite 100, Sugar Land, Tx 77478. NDC: 70092-1255-75 — Reason: Lack of Assurance of Sterility — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 2, 2025recall478d agoAscent Consumer Products Inc. recall (Cls I)Reynolds Consumer Products Inc.

    SinuCleanse Premixed SALINE PACKETS (sodium bicarbonate USP 700 mg and sodium chloride USP 2300 mg) for Nasal Wash System, 60-count All Natural USP Grade Saline Packets, Net WT 0.1OZ (3g) each, Distributed by Ascent Consumer Products Inc., Melville, NY 11747, UPC 6 46011 00103 4 — Reason: Microbial Contamination of Non-Sterile Products: Bacterial contamination with Staphylococcus aureus — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 2, 2025recall478d agoStrides Pharma, Inc. recall (Cls II)Strides Pharma Inc

    Testosterone Gel 1%, 5 grams, 30 Unit-dose Packets in a carton, Rx only, Distributed by: Strides Pharma Inc., East Brunswick, NJ, NDC 64380-152-02 — Reason: Presence of foreign substance: Presence of Benzene. — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 2, 2025recall478d agoJohnson, S C and Son, Inc recall (Cls II)

    babyganics, Sheer Blend, SPF 50 Mineral Sunscreen Fragrance Free (zinc oxide 20%), a) 1.7 FL OZ (50 mL) bottle, UPC 810035921658, b) 8 FL OZ (236 mL) bottle, UPC 810035921382, Dist. by KAS Direct, LLC, 1525 Howe St., Racine, WI 53403, Made in Canada. — Reason: Failed stability specifications: during routine stability monitoring quality concerns were identified. Physical separation for ingredients was observed. — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 2, 2025recall478d agoQuVa Pharma, Inc. recall (Cls II)IGC Pharma, Inc.

    fentaNYL Citrate PF 200 mcg/100 mL (2 mcg/ml) /0.2% ROPivacaine HCl 200 mg/100 mL (2 mg/mL), 100 ml in NS Yellow CADD FSFF, Injection for Epidural Use (Not intended For IV Use), Compounded, For Institutional or Office Use Only, QuVa Pharma, 1075 West Park One Drive, Suite 100, Sugar Land, Tx 77478. NDC: 70092-1259-75 — Reason: Lack of Assurance of Sterility — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 2, 2025recall478d agoStrides Pharma, Inc. recall (Cls II)Strides Pharma Inc

    Testosterone Gel 1%, 2.5 grams, 30 Unit-dose packets in a carton, Rx only, Distributed by: Strides Pharma Inc., East Brunswick, NJ, NDC 64380-151-02 — Reason: Presence of foreign substance: Presence of Benzene. — Status: Ongoing

    full page →fda recalls ↗
    recall
    471d ago
    The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories recall (Cls III)Teva Pharmaceuticals USA Inc

    Tolterodine Tartrate Extended-Release Capsules, 2 mg, 30 Capsules (3 x 10) Unit Dose carton, Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268 USA, NDC 0904-6592-04. — Reason: Failed Dissolution Specifications: Out of specification results obtained during routine stability testing for dissolution. — Status: Terminated

    full page →fda recalls ↗
    ›Apr 9, 2025recall471d agoImprimis NJOF, LLC recall (Cls III)Sawai Man Singh Medical College

    Tropicamide - Proparacaine - Phenylephrine - Ketorolac Sterile Ophthalmic Solution, 1% 0.5% 2.5% 0.5%, 5 mL fill in 15 mL bottle, Imprimis NJOF, LLC, Route 46 West, Unit 6B, Ledgewood, NJ, 07852, NDC: 71384-733-05. — Reason: Sub-Potent Drug: The stability batch showed a subpotent result, which does not meet the product specifications of 90.0-110.0% of the label claim. — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 9, 2025recall471d agoAmerisource Health Services LLC recall (Cls II)Greenstone LLC

    Voriconazole Tablets, 50 mg, packaged in cartons of 3 blister cards with 10 individual blistered doses (30 Unit Dose per carton), Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC 60687-294-21, Unit Dose NDC 60687-294-11. — Reason: cGMP Deviations: Received notification from their supplier requesting they perform a recall due to the fact they repackaged the product. — Status: Terminated

    full page →fda recalls ↗
    ›Apr 9, 2025recall471d agoBreckenridge Pharmaceutical, Inc. recall (Cls II)Breckenridge Pharmaceutical Inc

    Duloxetine Delayed-Release Capsules, USP, 30 mg, Rx Only, 1,000 Capsules per bottle, Manufactured by: Towa Pharmaceutical Europe, S.L., Martorelles, (Barcelona), Spain, Distributed by: Breckenridge Pharmaceutical, Inc., Berkley Heights, NJ 07922, NDC 51991-747-10. — Reason: CGMP Deviations: presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-nitroso-duloxetine, above the recommended interim limit. — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 9, 2025recall471d agoGlenmark Pharmaceuticals Inc., USA recall (Cls II)LB PHARMACEUTICALS INC

    chlorproMAZINE Hydrochloride Tablets, USP 100 mg, Rx Only, 100 Tablets per bottle, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, Product of India, NDC 68462-864-01 — Reason: CGMP deviations: presence of N-Nitroso-Desmethyl Chlorpromazine impurity above the recommended interim limit. — Status: Ongoing

    full page →fda recalls ↗
    recall
    464d ago
    Glenmark Pharmaceuticals Inc., USA recall (Cls II)LB PHARMACEUTICALS INC

    Cetirizine Hydrochloride Tablets, USP, 10mg, 365-count packs, Rx Only, Manufactured for: Glenmark Therapeutics Inc., Distributed by: Amazon. NDC# 72657-129-35 — Reason: CGMP Deviations — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 16, 2025recall464d agoASEGUA THERAPEUTICS LLC recall (Cls II)Asegua Therapeutics LLC

    Sofosbuvir and Velpatasvir, 400 mg/100 mg tablets, 28 tablets: 2x14 blister cards, Rx Only, Manufactured for: Asegua Therapeutics LLC an affiliate of Gilead Sciences, Inc., Foster City, CA 94404, Made in Ireland, NDC# 72626-2701-1 — Reason: Defective Container: blister packs not properly sealed resulting in tablets being loose in the carton. — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 16, 2025recall464d agoGlenmark Pharmaceuticals Inc., USA recall (Cls II)LB PHARMACEUTICALS INC

    Ranolazine Extended-Release Tablets 1000mg, 60-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430. NDC# 68462-320-60 — Reason: CGMP Deviations — Status: Ongoing

    full page →fda recalls ↗
    $AIRI
    $SGP
    $PBSV
    $CVS
    $PFE25.01+0.77%
    $ICUI153.46-2.53%
    $AMGN371.50+1.49%
    $REYN25.21-2.96%
    $MIRA0.9767-2.33%
    $AMGN371.50+1.49%
    $IGC0.2670+0.41%
    $CPHI0.7101-0.82%
    $IGC0.2670+0.41%
    $REYN25.21-2.96%
    $REYN25.21-2.96%
    $IGC0.2670+0.41%
    $LBRX34.62-3.40%
    $LBRX34.62-3.40%
    $LBRX34.62-3.40%